COMMUNIQUÉS West-GlobeNewswire
      -   
  
VALNEVA confirme ses prévisions 2018 et publie ses premières perspectives de chiffre d'affaires pour 2019
16/01/2019 -   
  
VALNEVA Announces New $59 Million IXIARO® Supply Contract with US Government
16/01/2019 -   
  
VALNEVA signe un nouveau contrat de $59 millions avec le gouvernement américain pour la fourniture de son vaccin IXIARO®
16/01/2019 -   
  
Stemline Therapeutics Announces Upsizing and Pricing of $80 Million Public Offering of Common Stock
16/01/2019 -   
  
ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders
16/01/2019 -   
  
Loop Industries Closes $4.5MM Private Placement
16/01/2019 -   
  
MPX Securityholders Overwhelming Approve Transformational Business Combination with iAnthus
16/01/2019 -   
  
Onconova Therapeutics Promotes Dr. Steven M. Fruchtman to Chief Executive Officer
15/01/2019 -   
  
HealthEC Recognized for Overall Performance in KLAS 2018 Population Health Management Part 1 Report
15/01/2019 -   
  
Microbot Medical Inc. Announces $5.9 Million Registered Direct Offering Priced At-the-Market
15/01/2019 -   
  
Relevium To Host Screenings of Documentary “Weed The People” Across Canada Today -- CFN Media
15/01/2019 -   
  
NeuroMetrix, Inc. Announces Fourth Quarter 2018 Financial Results Conference Call
15/01/2019 -   
  
Call for nominations seeks caregiving heroes to honour with Heart of Home Care Awards
15/01/2019 -   
  
Sienna Announces January Dividend
15/01/2019 -   
  
Molina Healthcare Announces Fourth Quarter and Year-End 2018 Earnings Release and Conference Call Dates
15/01/2019 -   
  
Holding(s) in Company
15/01/2019 -   
  
Information concerning the total number of voting rights and shares
15/01/2019 -   
  
Informations relatives au nombre total de droits de vote et d'actions
15/01/2019 -   
  
OSE Immunotherapeutics Receives First Notice of Allowance of a Patent for Use of Tedopi® to Treat Brain Metastasis
15/01/2019 
Pages